
XBiotech Inc.
NASDAQ:XBIT
Overview | Financials
Company Name | XBiotech Inc. |
Symbol | XBIT |
Currency | USD |
Price | 3.31 |
Market Cap | 100,900,385 |
Dividend Yield | 0% |
52-week-range | 2.94 - 9.96 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. John Simard |
Website | https://www.xbiotech.com |
An error occurred while fetching data.
About XBiotech Inc.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD